249 related articles for article (PubMed ID: 38414247)
41. Assessment of cochlear toxicity in response to chronic 3,3'-iminodipropionitrile in mice reveals early and reversible functional loss that precedes overt histopathology.
Greguske EA; Llorens J; Pyott SJ
Arch Toxicol; 2021 Mar; 95(3):1003-1021. PubMed ID: 33495873
[TBL] [Abstract][Full Text] [Related]
42. PITX2 functions as a transcription factor for GPX4 and protects pancreatic cancer cells from ferroptosis.
Wang Z; Wu D; Zhang Y; Chen W; Yang Y; Yang Y; Zu G; An Y; Yu X; Qin Y; Xu X; Chen X
Exp Cell Res; 2024 Jun; 439(1):114074. PubMed ID: 38710403
[TBL] [Abstract][Full Text] [Related]
43. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.
Mao C; Liu X; Zhang Y; Lei G; Yan Y; Lee H; Koppula P; Wu S; Zhuang L; Fang B; Poyurovsky MV; Olszewski K; Gan B
Nature; 2021 May; 593(7860):586-590. PubMed ID: 33981038
[TBL] [Abstract][Full Text] [Related]
44. Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs.
Su Y; Zhao B; Zhou L; Zhang Z; Shen Y; Lv H; AlQudsy LHH; Shang P
Cancer Lett; 2020 Jul; 483():127-136. PubMed ID: 32067993
[TBL] [Abstract][Full Text] [Related]
45. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
[TBL] [Abstract][Full Text] [Related]
46. Cisplatin-induced ototoxicity: From signaling network to therapeutic targets.
Wang X; Zhou Y; Wang D; Wang Y; Zhou Z; Ma X; Liu X; Dong Y
Biomed Pharmacother; 2023 Jan; 157():114045. PubMed ID: 36455457
[TBL] [Abstract][Full Text] [Related]
47. The central role of glutathione peroxidase 4 in the regulation of ferroptosis and its implications for pro-inflammatory cytokine-mediated beta-cell death.
Krümmel B; Plötz T; Jörns A; Lenzen S; Mehmeti I
Biochim Biophys Acta Mol Basis Dis; 2021 Jun; 1867(6):166114. PubMed ID: 33662571
[TBL] [Abstract][Full Text] [Related]
48. GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis.
Forcina GC; Dixon SJ
Proteomics; 2019 Sep; 19(18):e1800311. PubMed ID: 30888116
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-214-3p aggravates ferroptosis by targeting GPX4 in cisplatin-induced acute kidney injury.
Zhou J; Xiao C; Zheng S; Wang Q; Zhu H; Zhang Y; Wang R
Cell Stress Chaperones; 2022 Jul; 27(4):325-336. PubMed ID: 35366755
[TBL] [Abstract][Full Text] [Related]
50. Simultaneous regulation of ferroptosis suppressor protein 1 and glutathione peroxidase 4 as a new therapeutic strategy of ferroptosis for esophageal squamous cell carcinoma.
Miyauchi W; Shishido Y; Matsumi Y; Matsunaga T; Makinoya M; Shimizu S; Miyatani K; Sakamoto T; Umekita Y; Hasegawa T; Fujiwara Y
Esophagus; 2023 Jul; 20(3):492-501. PubMed ID: 36576648
[TBL] [Abstract][Full Text] [Related]
51. MITOL/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis.
Kitakata H; Endo J; Matsushima H; Yamamoto S; Ikura H; Hirai A; Koh S; Ichihara G; Hiraide T; Moriyama H; Shirakawa K; Goto S; Katsumata Y; Anzai A; Kataoka M; Tokuyama T; Ishido S; Yanagi S; Fukuda K; Sano M
J Mol Cell Cardiol; 2021 Dec; 161():116-129. PubMed ID: 34390730
[TBL] [Abstract][Full Text] [Related]
52. Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS/HO-1/GPX4 axis.
Lin Q; Li S; Jin H; Cai H; Zhu X; Yang Y; Wu J; Qi C; Shao X; Li J; Zhang K; Zhou W; Zhang M; Cheng J; Gu L; Mou S; Ni Z
Int J Biol Sci; 2023; 19(4):1192-1210. PubMed ID: 36923942
[TBL] [Abstract][Full Text] [Related]
53. Regulation of ACSL4-Catalyzed Lipid Peroxidation Process Resists Cisplatin Ototoxicity.
He F; Huang X; Wei G; Lin X; Zhang W; Zhuang W; He W; Zhan T; Hu H; Yang H
Oxid Med Cell Longev; 2022; 2022():3080263. PubMed ID: 35355868
[TBL] [Abstract][Full Text] [Related]
54. Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity.
Al Aameri RFH; Alanisi EMA; Oluwatosin A; Al Sallami D; Sheth S; Alberts I; Patel S; Rybak LP; Ramkumar V
Front Immunol; 2023; 14():1125948. PubMed ID: 37063917
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of CISD1 attenuates cisplatin-induced hearing loss in mice via the PI3K and MAPK pathways.
Dong W; Jiang Y; Yao Q; Xu M; Jin Y; Dong L; Li Z; Yu D
Biochem Pharmacol; 2024 May; 223():116132. PubMed ID: 38492782
[TBL] [Abstract][Full Text] [Related]
56. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity.
Xu C; Sun S; Johnson T; Qi R; Zhang S; Zhang J; Yang K
Cell Rep; 2021 Jun; 35(11):109235. PubMed ID: 34133924
[TBL] [Abstract][Full Text] [Related]
57. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
[TBL] [Abstract][Full Text] [Related]
58. FSP1 is a glutathione-independent ferroptosis suppressor.
Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
[TBL] [Abstract][Full Text] [Related]
59. Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice.
Rainey RN; Ng SY; Llamas J; van der Horst GT; Segil N
J Neurosci; 2016 Apr; 36(17):4758-70. PubMed ID: 27122034
[TBL] [Abstract][Full Text] [Related]
60. C-phycocyanin from
Kim YR; Do JM; Kim KH; Stoica AR; Jo SW; Kim UK; Yoon HS
Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 31010222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
